Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

107,369 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells.
Eskew JD, Sadikot T, Morales P, Duren A, Dunwiddie I, Swink M, Zhang X, Hembruff S, Donnelly A, Rajewski RA, Blagg BS, Manjarrez JR, Matts RL, Holzbeierlein JM, Vielhauer GA. Eskew JD, et al. Among authors: zhang x. BMC Cancer. 2011 Oct 31;11:468. doi: 10.1186/1471-2407-11-468. BMC Cancer. 2011. PMID: 22039910 Free PMC article.
CDK5RAP2 is required for spindle checkpoint function.
Zhang X, Liu D, Lv S, Wang H, Zhong X, Liu B, Wang B, Liao J, Li J, Pfeifer GP, Xu X. Zhang X, et al. Cell Cycle. 2009 Apr 15;8(8):1206-16. doi: 10.4161/cc.8.8.8205. Epub 2009 Apr 16. Cell Cycle. 2009. PMID: 19282672 Free PMC article.
AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients.
Xu X, Mao L, Xu W, Tang W, Zhang X, Xi B, Xu R, Fang X, Liu J, Fang C, Zhao L, Wang X, Jiang J, Hu P, Zhao H, Zhang L. Xu X, et al. Among authors: zhang l, zhang x. Mol Cancer Ther. 2016 Nov;15(11):2586-2597. doi: 10.1158/1535-7163.MCT-16-0281. Epub 2016 Aug 29. Mol Cancer Ther. 2016. PMID: 27573423
107,369 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page